Autoimmune diabetes mellitus after COVID-19 vaccination in adult population: a systematic review of case reports.

ABSTRACT:

Background

Autoimmune/type 1 diabetes mellitus (T1DM) is a recently described rare occurrence following the administration of adjuvants such as coronavirus disease 2019 (COVID-19) vaccines. This systematic review aimed to review all available literature on the potential association between COVID-19 vaccines and T1DM.

Methods

The Directory of Open Access Journals, MEDLINE, Google Scholar, and Scopus were systematically searched for all published studies from inception to July 2022. Articles reporting T1DM development within 8 weeks of administration of COVID-19 vaccine were included. Two reviewers independently performed the risk of bias assessment following the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Case Reports.

Results

Eight eligible studies

SUBMITTER: Alsudais AS 

PROVIDER: S-EPMC10403898 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature